Rivaroxaban API Market - Global Outlook and Forecast 2023-2027

Report ID: 744501 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Rivaroxaban API Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Rivaroxaban API Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Rivaroxaban API Overall Market Size
    2.1 Global Rivaroxaban API Market Size: 2021 VS 2027
    2.2 Global Rivaroxaban API Revenue, Prospects & Forecasts: 2016-2027
    2.3 Global Rivaroxaban API Sales (Consumption): 2016-2027
3 Company Landscape
    3.1 Top Rivaroxaban API Players in Global Market
    3.2 Top Global Rivaroxaban API Companies Ranked by Revenue
    3.3 Global Rivaroxaban API Revenue by Companies
    3.4 Global Rivaroxaban API Sales by Companies
    3.5 Global Rivaroxaban API Price by Manufacturer (2016-2021)
    3.6 Top 3 and Top 5 Rivaroxaban API Companies in Global Market, by Revenue in 2020
    3.7 Global Manufacturers Rivaroxaban API Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Rivaroxaban API Players in Global Market
        3.8.1 List of Global Tier 1 Rivaroxaban API Companies
        3.8.2 List of Global Tier 2 and Tier 3 Rivaroxaban API Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Rivaroxaban API Market Size Markets, 2021 & 2027
        4.1.2 Purity≥98%
        4.1.3 Purity<98%
    4.2 By Type - Global Rivaroxaban API Revenue & Forecasts
        4.2.1 By Type - Global Rivaroxaban API Revenue, 2016-2021
        4.2.2 By Type - Global Rivaroxaban API Revenue, 2022-2027
        4.2.3 By Type - Global Rivaroxaban API Revenue Market Share, 2016-2027
    4.3 By Type - Global Rivaroxaban API Sales & Forecasts
        4.3.1 By Type - Global Rivaroxaban API Sales, 2016-2021
        4.3.2 By Type - Global Rivaroxaban API Sales, 2022-2027
        4.3.3 By Type - Global Rivaroxaban API Sales Market Share, 2016-2027
    4.4 By Type - Global Rivaroxaban API Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Rivaroxaban API Market Size, 2021 & 2027
        5.1.2 Rivaroxaban Tablets
        5.1.3 Others
    5.2 By Application - Global Rivaroxaban API Revenue & Forecasts
        5.2.1 By Application - Global Rivaroxaban API Revenue, 2016-2021
        5.2.2 By Application - Global Rivaroxaban API Revenue, 2022-2027
        5.2.3 By Application - Global Rivaroxaban API Revenue Market Share, 2016-2027
    5.3 By Application - Global Rivaroxaban API Sales & Forecasts
        5.3.1 By Application - Global Rivaroxaban API Sales, 2016-2021
        5.3.2 By Application - Global Rivaroxaban API Sales, 2022-2027
        5.3.3 By Application - Global Rivaroxaban API Sales Market Share, 2016-2027
    5.4 By Application - Global Rivaroxaban API Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
    6.1 By Region - Global Rivaroxaban API Market Size, 2021 & 2027
    6.2 By Region - Global Rivaroxaban API Revenue & Forecasts
        6.2.1 By Region - Global Rivaroxaban API Revenue, 2016-2021
        6.2.2 By Region - Global Rivaroxaban API Revenue, 2022-2027
        6.2.3 By Region - Global Rivaroxaban API Revenue Market Share, 2016-2027
    6.3 By Region - Global Rivaroxaban API Sales & Forecasts
        6.3.1 By Region - Global Rivaroxaban API Sales, 2016-2021
        6.3.2 By Region - Global Rivaroxaban API Sales, 2022-2027
        6.3.3 By Region - Global Rivaroxaban API Sales Market Share, 2016-2027
    6.4 North America
        6.4.1 By Country - North America Rivaroxaban API Revenue, 2016-2027
        6.4.2 By Country - North America Rivaroxaban API Sales, 2016-2027
        6.4.3 US Rivaroxaban API Market Size, 2016-2027
        6.4.4 Canada Rivaroxaban API Market Size, 2016-2027
        6.4.5 Mexico Rivaroxaban API Market Size, 2016-2027
    6.5 Europe
        6.5.1 By Country - Europe Rivaroxaban API Revenue, 2016-2027
        6.5.2 By Country - Europe Rivaroxaban API Sales, 2016-2027
        6.5.3 Germany Rivaroxaban API Market Size, 2016-2027
        6.5.4 France Rivaroxaban API Market Size, 2016-2027
        6.5.5 U.K. Rivaroxaban API Market Size, 2016-2027
        6.5.6 Italy Rivaroxaban API Market Size, 2016-2027
        6.5.7 Russia Rivaroxaban API Market Size, 2016-2027
        6.5.8 Nordic Countries Rivaroxaban API Market Size, 2016-2027
        6.5.9 Benelux Rivaroxaban API Market Size, 2016-2027
    6.6 Asia
        6.6.1 By Region - Asia Rivaroxaban API Revenue, 2016-2027
        6.6.2 By Region - Asia Rivaroxaban API Sales, 2016-2027
        6.6.3 China Rivaroxaban API Market Size, 2016-2027
        6.6.4 Japan Rivaroxaban API Market Size, 2016-2027
        6.6.5 South Korea Rivaroxaban API Market Size, 2016-2027
        6.6.6 Southeast Asia Rivaroxaban API Market Size, 2016-2027
        6.6.7 India Rivaroxaban API Market Size, 2016-2027
    6.7 South America
        6.7.1 By Country - South America Rivaroxaban API Revenue, 2016-2027
        6.7.2 By Country - South America Rivaroxaban API Sales, 2016-2027
        6.7.3 Brazil Rivaroxaban API Market Size, 2016-2027
        6.7.4 Argentina Rivaroxaban API Market Size, 2016-2027
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Rivaroxaban API Revenue, 2016-2027
        6.8.2 By Country - Middle East & Africa Rivaroxaban API Sales, 2016-2027
        6.8.3 Turkey Rivaroxaban API Market Size, 2016-2027
        6.8.4 Israel Rivaroxaban API Market Size, 2016-2027
        6.8.5 Saudi Arabia Rivaroxaban API Market Size, 2016-2027
        6.8.6 UAE Rivaroxaban API Market Size, 2016-2027
7 Manufacturers & Brands Profiles
    7.1 Piramal Enterprises Limited
        7.1.1 Piramal Enterprises Limited Corporate Summary
        7.1.2 Piramal Enterprises Limited Business Overview
        7.1.3 Piramal Enterprises Limited Rivaroxaban API Major Product Offerings
        7.1.4 Piramal Enterprises Limited Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.1.5 Piramal Enterprises Limited Key News
    7.2 Dr. Reddy's Laboratories
        7.2.1 Dr. Reddy's Laboratories Corporate Summary
        7.2.2 Dr. Reddy's Laboratories Business Overview
        7.2.3 Dr. Reddy's Laboratories Rivaroxaban API Major Product Offerings
        7.2.4 Dr. Reddy's Laboratories Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.2.5 Dr. Reddy's Laboratories Key News
    7.3 Polpharma S. A.
        7.3.1 Polpharma S. A. Corporate Summary
        7.3.2 Polpharma S. A. Business Overview
        7.3.3 Polpharma S. A. Rivaroxaban API Major Product Offerings
        7.3.4 Polpharma S. A. Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.3.5 Polpharma S. A. Key News
    7.4 ZCL Chemicals Limited
        7.4.1 ZCL Chemicals Limited Corporate Summary
        7.4.2 ZCL Chemicals Limited Business Overview
        7.4.3 ZCL Chemicals Limited Rivaroxaban API Major Product Offerings
        7.4.4 ZCL Chemicals Limited Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.4.5 ZCL Chemicals Limited Key News
    7.5 Interquim SA
        7.5.1 Interquim SA Corporate Summary
        7.5.2 Interquim SA Business Overview
        7.5.3 Interquim SA Rivaroxaban API Major Product Offerings
        7.5.4 Interquim SA Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.5.5 Interquim SA Key News
    7.6 Medichem S.A
        7.6.1 Medichem S.A Corporate Summary
        7.6.2 Medichem S.A Business Overview
        7.6.3 Medichem S.A Rivaroxaban API Major Product Offerings
        7.6.4 Medichem S.A Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.6.5 Medichem S.A Key News
    7.7 UQUIFA
        7.7.1 UQUIFA Corporate Summary
        7.7.2 UQUIFA Business Overview
        7.7.3 UQUIFA Rivaroxaban API Major Product Offerings
        7.4.4 UQUIFA Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.7.5 UQUIFA Key News
    7.8 Inke
        7.8.1 Inke Corporate Summary
        7.8.2 Inke Business Overview
        7.8.3 Inke Rivaroxaban API Major Product Offerings
        7.8.4 Inke Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.8.5 Inke Key News
    7.9 Tecoland
        7.9.1 Tecoland Corporate Summary
        7.9.2 Tecoland Business Overview
        7.9.3 Tecoland Rivaroxaban API Major Product Offerings
        7.9.4 Tecoland Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.9.5 Tecoland Key News
    7.10 Teva Pharmaceutical Industries Ltd.
        7.10.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
        7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
        7.10.3 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Major Product Offerings
        7.10.4 Teva Pharmaceutical Industries Ltd. Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.10.5 Teva Pharmaceutical Industries Ltd. Key News
    7.11 Symed Labs Limited
        7.11.1 Symed Labs Limited Corporate Summary
        7.11.2 Symed Labs Limited Rivaroxaban API Business Overview
        7.11.3 Symed Labs Limited Rivaroxaban API Major Product Offerings
        7.11.4 Symed Labs Limited Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.11.5 Symed Labs Limited Key News
    7.12 Unichem Laboratories Limited
        7.12.1 Unichem Laboratories Limited Corporate Summary
        7.12.2 Unichem Laboratories Limited Rivaroxaban API Business Overview
        7.12.3 Unichem Laboratories Limited Rivaroxaban API Major Product Offerings
        7.12.4 Unichem Laboratories Limited Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.12.5 Unichem Laboratories Limited Key News
    7.13 Lupin Ltd
        7.13.1 Lupin Ltd Corporate Summary
        7.13.2 Lupin Ltd Rivaroxaban API Business Overview
        7.13.3 Lupin Ltd Rivaroxaban API Major Product Offerings
        7.13.4 Lupin Ltd Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.13.5 Lupin Ltd Key News
    7.14 Neuland Laboratories
        7.14.1 Neuland Laboratories Corporate Summary
        7.14.2 Neuland Laboratories Business Overview
        7.14.3 Neuland Laboratories Rivaroxaban API Major Product Offerings
        7.14.4 Neuland Laboratories Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.14.5 Neuland Laboratories Key News
    7.15 NG ZIP CHEMICAL INDUSTRIAL
        7.15.1 NG ZIP CHEMICAL INDUSTRIAL Corporate Summary
        7.15.2 NG ZIP CHEMICAL INDUSTRIAL Business Overview
        7.15.3 NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Major Product Offerings
        7.15.4 NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.15.5 NG ZIP CHEMICAL INDUSTRIAL Key News
    7.16 Zhejiang Huahai Pharmaceutial. Co., Ltd.
        7.16.1 Zhejiang Huahai Pharmaceutial. Co., Ltd. Corporate Summary
        7.16.2 Zhejiang Huahai Pharmaceutial. Co., Ltd. Business Overview
        7.16.3 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Major Product Offerings
        7.16.4 Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.16.5 Zhejiang Huahai Pharmaceutial. Co., Ltd. Key News
    7.17 Glenmark Pharmaceuticals
        7.17.1 Glenmark Pharmaceuticals Corporate Summary
        7.17.2 Glenmark Pharmaceuticals Business Overview
        7.17.3 Glenmark Pharmaceuticals Rivaroxaban API Major Product Offerings
        7.17.4 Glenmark Pharmaceuticals Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.17.5 Glenmark Pharmaceuticals Key News
    7.18 Srini Pharmaceuticals Private Limited
        7.18.1 Srini Pharmaceuticals Private Limited Corporate Summary
        7.18.2 Srini Pharmaceuticals Private Limited Business Overview
        7.18.3 Srini Pharmaceuticals Private Limited Rivaroxaban API Major Product Offerings
        7.18.4 Srini Pharmaceuticals Private Limited Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.18.5 Srini Pharmaceuticals Private Limited Key News
    7.19 Jiangxi Synergy Pharmaceutical Co., Ltd
        7.19.1 Jiangxi Synergy Pharmaceutical Co., Ltd Corporate Summary
        7.19.2 Jiangxi Synergy Pharmaceutical Co., Ltd Business Overview
        7.19.3 Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Major Product Offerings
        7.19.4 Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.19.5 Jiangxi Synergy Pharmaceutical Co., Ltd Key News
    7.20 Lunan Pharmaceutical Group
        7.20.1 Lunan Pharmaceutical Group Corporate Summary
        7.20.2 Lunan Pharmaceutical Group Business Overview
        7.20.3 Lunan Pharmaceutical Group Rivaroxaban API Major Product Offerings
        7.20.4 Lunan Pharmaceutical Group Rivaroxaban API Sales and Revenue in Global (2016-2021)
        7.20.5 Lunan Pharmaceutical Group Key News
8 Global Rivaroxaban API Production Capacity, Analysis
    8.1 Global Rivaroxaban API Production Capacity, 2016-2027
    8.2 Rivaroxaban API Production Capacity of Key Manufacturers in Global Market
    8.3 Global Rivaroxaban API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Rivaroxaban API Supply Chain Analysis
    10.1 Rivaroxaban API Industry Value Chain
    10.2 Rivaroxaban API Upstream Market
    10.3 Rivaroxaban API Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Rivaroxaban API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer
List of Tables
    Table 1. Key Players of Rivaroxaban API in Global Market
    Table 2. Top Rivaroxaban API Players in Global Market, Ranking by Revenue (2019)
    Table 3. Global Rivaroxaban API Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. Global Rivaroxaban API Revenue Share by Companies, 2016-2021
    Table 5. Global Rivaroxaban API Sales by Companies, (Ton), 2016-2021
    Table 6. Global Rivaroxaban API Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Rivaroxaban API Price (2016-2021) & (US$/Ton)
    Table 8. Global Manufacturers Rivaroxaban API Product Type
    Table 9. List of Global Tier 1 Rivaroxaban API Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Rivaroxaban API Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. By Type – Global Rivaroxaban API Revenue, (US$, Mn), 2021 VS 2027
    Table 12. By Type - Global Rivaroxaban API Revenue (US$, Mn), 2016-2021
    Table 13. By Type - Global Rivaroxaban API Revenue (US$, Mn), 2022-2027
    Table 14. By Type - Global Rivaroxaban API Sales (Ton), 2016-2021
    Table 15. By Type - Global Rivaroxaban API Sales (Ton), 2022-2027
    Table 16. By Application – Global Rivaroxaban API Revenue, (US$, Mn), 2021 VS 2027
    Table 17. By Application - Global Rivaroxaban API Revenue (US$, Mn), 2016-2021
    Table 18. By Application - Global Rivaroxaban API Revenue (US$, Mn), 2022-2027
    Table 19. By Application - Global Rivaroxaban API Sales (Ton), 2016-2021
    Table 20. By Application - Global Rivaroxaban API Sales (Ton), 2022-2027
    Table 21. By Region – Global Rivaroxaban API Revenue, (US$, Mn), 2021 VS 2027
    Table 22. By Region - Global Rivaroxaban API Revenue (US$, Mn), 2016-2021
    Table 23. By Region - Global Rivaroxaban API Revenue (US$, Mn), 2022-2027
    Table 24. By Region - Global Rivaroxaban API Sales (Ton), 2016-2021
    Table 25. By Region - Global Rivaroxaban API Sales (Ton), 2022-2027
    Table 26. By Country - North America Rivaroxaban API Revenue, (US$, Mn), 2016-2021
    Table 27. By Country - North America Rivaroxaban API Revenue, (US$, Mn), 2022-2027
    Table 28. By Country - North America Rivaroxaban API Sales, (Ton), 2016-2021
    Table 29. By Country - North America Rivaroxaban API Sales, (Ton), 2022-2027
    Table 30. By Country - Europe Rivaroxaban API Revenue, (US$, Mn), 2016-2021
    Table 31. By Country - Europe Rivaroxaban API Revenue, (US$, Mn), 2022-2027
    Table 32. By Country - Europe Rivaroxaban API Sales, (Ton), 2016-2021
    Table 33. By Country - Europe Rivaroxaban API Sales, (Ton), 2022-2027
    Table 34. By Region - Asia Rivaroxaban API Revenue, (US$, Mn), 2016-2021
    Table 35. By Region - Asia Rivaroxaban API Revenue, (US$, Mn), 2022-2027
    Table 36. By Region - Asia Rivaroxaban API Sales, (Ton), 2016-2021
    Table 37. By Region - Asia Rivaroxaban API Sales, (Ton), 2022-2027
    Table 38. By Country - South America Rivaroxaban API Revenue, (US$, Mn), 2016-2021
    Table 39. By Country - South America Rivaroxaban API Revenue, (US$, Mn), 2022-2027
    Table 40. By Country - South America Rivaroxaban API Sales, (Ton), 2016-2021
    Table 41. By Country - South America Rivaroxaban API Sales, (Ton), 2022-2027
    Table 42. By Country - Middle East & Africa Rivaroxaban API Revenue, (US$, Mn), 2016-2021
    Table 43. By Country - Middle East & Africa Rivaroxaban API Revenue, (US$, Mn), 2022-2027
    Table 44. By Country - Middle East & Africa Rivaroxaban API Sales, (Ton), 2016-2021
    Table 45. By Country - Middle East & Africa Rivaroxaban API Sales, (Ton), 2022-2027
    Table 46. Piramal Enterprises Limited Corporate Summary
    Table 47. Piramal Enterprises Limited Rivaroxaban API Product Offerings
    Table 48. Piramal Enterprises Limited Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 49. Dr. Reddy's Laboratories Corporate Summary
    Table 50. Dr. Reddy's Laboratories Rivaroxaban API Product Offerings
    Table 51. Dr. Reddy's Laboratories Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 52. Polpharma S. A. Corporate Summary
    Table 53. Polpharma S. A. Rivaroxaban API Product Offerings
    Table 54. Polpharma S. A. Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 55. ZCL Chemicals Limited Corporate Summary
    Table 56. ZCL Chemicals Limited Rivaroxaban API Product Offerings
    Table 57. ZCL Chemicals Limited Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 58. Interquim SA Corporate Summary
    Table 59. Interquim SA Rivaroxaban API Product Offerings
    Table 60. Interquim SA Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 61. Medichem S.A Corporate Summary
    Table 62. Medichem S.A Rivaroxaban API Product Offerings
    Table 63. Medichem S.A Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 64. UQUIFA Corporate Summary
    Table 65. UQUIFA Rivaroxaban API Product Offerings
    Table 66. UQUIFA Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 67. Inke Corporate Summary
    Table 68. Inke Rivaroxaban API Product Offerings
    Table 69. Inke Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 70. Tecoland Corporate Summary
    Table 71. Tecoland Rivaroxaban API Product Offerings
    Table 72. Tecoland Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 73. Teva Pharmaceutical Industries Ltd. Corporate Summary
    Table 74. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Product Offerings
    Table 75. Teva Pharmaceutical Industries Ltd. Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 76. Symed Labs Limited Corporate Summary
    Table 77. Symed Labs Limited Rivaroxaban API Product Offerings
    Table 78. Symed Labs Limited Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 79. Unichem Laboratories Limited Corporate Summary
    Table 80. Unichem Laboratories Limited Rivaroxaban API Product Offerings
    Table 81. Unichem Laboratories Limited Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 82. Lupin Ltd Corporate Summary
    Table 83. Lupin Ltd Rivaroxaban API Product Offerings
    Table 84. Lupin Ltd Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 85. Neuland Laboratories Corporate Summary
    Table 86. Neuland Laboratories Rivaroxaban API Product Offerings
    Table 87. Neuland Laboratories Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 88. NG ZIP CHEMICAL INDUSTRIAL Corporate Summary
    Table 89. NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Product Offerings
    Table 90. NG ZIP CHEMICAL INDUSTRIAL Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 91. Zhejiang Huahai Pharmaceutial. Co., Ltd. Corporate Summary
    Table 92. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Product Offerings
    Table 93. Zhejiang Huahai Pharmaceutial. Co., Ltd. Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 94. Glenmark Pharmaceuticals Corporate Summary
    Table 95. Glenmark Pharmaceuticals Rivaroxaban API Product Offerings
    Table 96. Glenmark Pharmaceuticals Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 97. Srini Pharmaceuticals Private Limited Corporate Summary
    Table 98. Srini Pharmaceuticals Private Limited Rivaroxaban API Product Offerings
    Table 99. Srini Pharmaceuticals Private Limited Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 100. Jiangxi Synergy Pharmaceutical Co., Ltd Corporate Summary
    Table 101. Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Product Offerings
    Table 102. Jiangxi Synergy Pharmaceutical Co., Ltd Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 103. Lunan Pharmaceutical Group Corporate Summary
    Table 104. Lunan Pharmaceutical Group Rivaroxaban API Product Offerings
    Table 105. Lunan Pharmaceutical Group Rivaroxaban API Sales (Ton), Revenue (US$, Mn) and Average Price (US$/Ton) (2016-2021)
    Table 106. Rivaroxaban API Production Capacity (Ton) of Key Manufacturers in Global Market, 2019-2021 (Ton)
    Table 107. Global Rivaroxaban API Capacity Market Share of Key Manufacturers, 2019-2021
    Table 108. Global Rivaroxaban API Production by Region, 2016-2021 (Ton)
    Table 109. Global Rivaroxaban API Production by Region, 2022-2027 (Ton)
    Table 110. Rivaroxaban API Market Opportunities & Trends in Global Market
    Table 111. Rivaroxaban API Market Drivers in Global Market
    Table 112. Rivaroxaban API Market Restraints in Global Market
    Table 113. Rivaroxaban API Raw Materials
    Table 114. Rivaroxaban API Raw Materials Suppliers in Global Market
    Table 115. Typical Rivaroxaban API Downstream
    Table 116. Rivaroxaban API Downstream Clients in Global Market
    Table 117. Rivaroxaban API Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Rivaroxaban API Segment by Type
    Figure 2. Rivaroxaban API Segment by Application
    Figure 3. Global Rivaroxaban API Market Overview: 2020
    Figure 4. Key Caveats
    Figure 5. Global Rivaroxaban API Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. Global Rivaroxaban API Revenue, 2016-2027 (US$, Mn)
    Figure 7. Rivaroxaban API Sales in Global Market: 2016-2027 (Ton)
    Figure 8. The Top 3 and 5 Players Market Share by Rivaroxaban API Revenue in 2020
    Figure 9. By Type - Global Rivaroxaban API Sales Market Share, 2016-2027
    Figure 10. By Type - Global Rivaroxaban API Revenue Market Share, 2016-2027
    Figure 11. By Type - Global Rivaroxaban API Price (US$/Ton), 2016-2027
    Figure 12. By Application - Global Rivaroxaban API Sales Market Share, 2016-2027
    Figure 13. By Application - Global Rivaroxaban API Revenue Market Share, 2016-2027
    Figure 14. By Application - Global Rivaroxaban API Price (US$/Ton), 2016-2027
    Figure 15. By Region - Global Rivaroxaban API Sales Market Share, 2016-2027
    Figure 16. By Region - Global Rivaroxaban API Revenue Market Share, 2016-2027
    Figure 17. By Country - North America Rivaroxaban API Revenue Market Share, 2016-2027
    Figure 18. By Country - North America Rivaroxaban API Sales Market Share, 2016-2027
    Figure 19. US Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 20. Canada Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 21. Mexico Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 22. By Country - Europe Rivaroxaban API Revenue Market Share, 2016-2027
    Figure 23. By Country - Europe Rivaroxaban API Sales Market Share, 2016-2027
    Figure 24. Germany Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 25. France Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 26. U.K. Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 27. Italy Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 28. Russia Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 29. Nordic Countries Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 30. Benelux Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 31. By Region - Asia Rivaroxaban API Revenue Market Share, 2016-2027
    Figure 32. By Region - Asia Rivaroxaban API Sales Market Share, 2016-2027
    Figure 33. China Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 34. Japan Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 35. South Korea Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 36. Southeast Asia Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 37. India Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 38. By Country - South America Rivaroxaban API Revenue Market Share, 2016-2027
    Figure 39. By Country - South America Rivaroxaban API Sales Market Share, 2016-2027
    Figure 40. Brazil Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 41. Argentina Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 42. By Country - Middle East & Africa Rivaroxaban API Revenue Market Share, 2016-2027
    Figure 43. By Country - Middle East & Africa Rivaroxaban API Sales Market Share, 2016-2027
    Figure 44. Turkey Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 45. Israel Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 46. Saudi Arabia Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 47. UAE Rivaroxaban API Revenue, (US$, Mn), 2016-2027
    Figure 48. Global Rivaroxaban API Production Capacity (Ton), 2016-2027
    Figure 49. The Percentage of Production Rivaroxaban API by Region, 2020 VS 2027
    Figure 50. Rivaroxaban API Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Rivaroxaban API Market In Chemical & Material report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rivaroxaban API Market In Chemical & Material report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rivaroxaban API Market In Chemical & Material report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports